Share on StockTwits
 

Opko Health (NYSE:OPK) Chairman Jane Ph D. Hsiao acquired 10,000 shares of the stock on the open market in a transaction that occurred on Thursday, January 30th. The stock was purchased at an average cost of $8.14 per share, with a total value of $81,400.00. Following the transaction, the chairman now directly owns 21,328,212 shares of the company’s stock, valued at approximately $173,611,646. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Several analysts have recently commented on the stock. Analysts at Barrington Research raised their price target on shares of Opko Health to $11.00 in a research note to investors on Friday, December 20th. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Opko Health in a research note to investors on Wednesday, December 18th. Finally, analysts at Jefferies Group raised their price target on shares of Opko Health from $10.00 to $11.50 in a research note to investors on Wednesday, November 13th. They now have a “buy” rating on the stock.

Shares of Opko Health (NYSE:OPK) traded down 2.70% on Friday, hitting $7.93. 3,315,231 shares of the company’s stock traded hands. Opko Health has a 52-week low of $6.08 and a 52-week high of $12.95. The stock’s 50-day moving average is $8.66 and its 200-day moving average is $9.10. The company’s market cap is $3.235 billion.

OPKO Health, Inc (NYSE:OPK), incorporated in October 1991, is a multi-national pharmaceutical and diagnostics company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.